Xeris Biopharma Holdings, Inc. XERS Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive Income (Loss), Net of Tax, Attributable to Parent at other companies
Other financials
Where this comes from
Reported directly by Xeris Biopharma Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ComprehensiveIncomeNetOfTax.
The official record: Xeris Biopharma Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xeris Biopharma Holdings, Inc.'s comprehensive income (loss), net of tax, attributable to parent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Xeris Biopharma Holdings, Inc.'s comprehensive income (loss), net of tax, attributable to parent?
- Xeris Biopharma Holdings, Inc. (XERS) reported comprehensive income (loss), net of tax, attributable to parent of $2.24M in Q1 2026.
- How has Xeris Biopharma Holdings, Inc.'s comprehensive income (loss), net of tax, attributable to parent changed year-over-year?
- Xeris Biopharma Holdings, Inc.'s comprehensive income (loss), net of tax, attributable to parent increased by 124.2% year-over-year, from -$9.22M to $2.24M.
- What is the long-term trend for Xeris Biopharma Holdings, Inc.'s comprehensive income (loss), net of tax, attributable to parent?
- Over 4 years (2021 to 2025), Xeris Biopharma Holdings, Inc.'s comprehensive income (loss), net of tax, attributable to parent has grown at a -74.1% compound annual growth rate (CAGR), from -$122.76M to $554K.
- What does comprehensive income (loss), net of tax, attributable to parent mean?
- This metric represents the total change in equity resulting from both net income and other comprehensive income items, such as unrealized gains or losses on securities and foreign currency translation adjustments. It provides a holistic view of the company's financial performance by incorporating non-operating gains and losses that bypass the traditional income statement. Investors use this to assess the total impact of all financial activities on the company's net worth.